Correlation Between Innovative Medical and Wuhan Hvsen

Can any of the company-specific risk be diversified away by investing in both Innovative Medical and Wuhan Hvsen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innovative Medical and Wuhan Hvsen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Innovative Medical Management and Wuhan Hvsen Biotechnology, you can compare the effects of market volatilities on Innovative Medical and Wuhan Hvsen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innovative Medical with a short position of Wuhan Hvsen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innovative Medical and Wuhan Hvsen.

Diversification Opportunities for Innovative Medical and Wuhan Hvsen

0.49

Correlation Coefficient

Innovative Medical  Wuhan Hvsen

Very weak diversification

The 3 months correlation between Innovative and Wuhan is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Innovative Medical Management and Wuhan Hvsen Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Wuhan Hvsen Biotechnology and Innovative Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innovative Medical Management are associated (or correlated) with Wuhan Hvsen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Wuhan Hvsen Biotechnology has no effect on the direction of Innovative Medical i.e., Innovative Medical and Wuhan Hvsen go up and down completely randomly.

Pair Corralation between Innovative Medical and Wuhan Hvsen

Assuming the 90 days trading horizon Innovative Medical Management is expected to generate 1.65 times more return on investment than Wuhan Hvsen. However, Innovative Medical is 1.65 times more volatile than Wuhan Hvsen Biotechnology. It trades about 0.03 of its potential returns per unit of risk. Wuhan Hvsen Biotechnology is currently generating about -0.08 per unit of risk. If you would invest  917.00  in Innovative Medical Management on December 2, 2024 and sell it today you would earn a total of  19.00  from holding Innovative Medical Management or generate 2.07% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Innovative Medical Management  vs.  Wuhan Hvsen Biotechnology

Innovative Medical

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Innovative Medical Management are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Innovative Medical may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Wuhan Hvsen Biotechnology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Wuhan Hvsen Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Innovative Medical and Wuhan Hvsen

The main advantage of trading using opposite Innovative Medical and Wuhan Hvsen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innovative Medical position performs unexpectedly, Wuhan Hvsen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wuhan Hvsen will offset losses from the drop in Wuhan Hvsen's long position.

The idea behind Innovative Medical Management and Wuhan Hvsen Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.